| Title |
Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, November 2011
|
| DOI | 10.1007/s00228-011-1161-x |
| Pubmed ID | |
| Authors |
P. Zarogoulidis, N. Papanas, I. Kioumis, E. Chatzaki, E. Maltezos, K. Zarogoulidis |
| Abstract |
Macrolides have long been recognised to exert immunomodulary and anti-inflammatory actions. They are able to suppress the "cytokine storm" of inflammation and to confer an additional clinical benefit through their immunomodulatory properties. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 25% |
| Australia | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 265 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| United Kingdom | 1 | <1% |
| France | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 261 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 31 | 12% |
| Student > Bachelor | 31 | 12% |
| Student > Master | 29 | 11% |
| Student > Ph. D. Student | 26 | 10% |
| Other | 19 | 7% |
| Other | 64 | 24% |
| Unknown | 65 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 89 | 34% |
| Pharmacology, Toxicology and Pharmaceutical Science | 28 | 11% |
| Agricultural and Biological Sciences | 17 | 6% |
| Biochemistry, Genetics and Molecular Biology | 16 | 6% |
| Immunology and Microbiology | 11 | 4% |
| Other | 31 | 12% |
| Unknown | 73 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2023.
All research outputs
#1,306,769
of 23,862,416 outputs
Outputs from European Journal of Clinical Pharmacology
#62
of 2,635 outputs
Outputs of similar age
#8,524
of 245,381 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#1
of 28 outputs
Altmetric has tracked 23,862,416 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,635 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,381 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.